Fig. 2
From: Elevated UBC9 expression and its oncogenic role in colorectal cancer progression and chemoresistance
Correlation analysis of UBE2I with clinical characteristics of colorectal cancer. (A–F) Correlation analysis of UBE2I expression with clinical characteristics of colorectal cancer patients, including (A) age, (B) gender, (C) microsatellites, (D) TV stage, (E) M stage, and (F) overall stage. (G) Analysis of gene variation differences between the UBE2I-Low and UBE2I-High groups; (H) GSEA analysis of signaling pathways enriched in the UBE2I high expression group; (I) Correlation analysis of UBE2I expression with immune cell infiltration.
